These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22296687)

  • 1. The use of darbepoetin to stimulate erythropoiesis in anemia of chronic kidney disease in cats: 25 cases.
    Chalhoub S; Langston CE; Farrelly J
    J Vet Intern Med; 2012; 26(2):363-9. PubMed ID: 22296687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Use of Darbepoetin to Stimulate Erythropoiesis in the Treatment of Anemia of Chronic Kidney Disease in Dogs.
    Fiocchi EH; Cowgill LD; Brown DC; Markovich JE; Tucker S; Labato MA; Callan MB
    J Vet Intern Med; 2017 Mar; 31(2):476-485. PubMed ID: 28256075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anemia of renal disease: what it is, what to do and what's new.
    Chalhoub S; Langston C; Eatroff A
    J Feline Med Surg; 2011 Sep; 13(9):629-40. PubMed ID: 21872790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemoglobin stability in patients with anemia, CKD, and type 2 diabetes: an analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) placebo arm.
    Skali H; Lin J; Pfeffer MA; Chen CY; Cooper ME; McMurray JJ; Nissenson AR; Remuzzi G; Rossert J; Parfrey PS; Scott-Douglas NW; Singh AK; Toto R; Uno H; Ivanovich P
    Am J Kidney Dis; 2013 Feb; 61(2):238-46. PubMed ID: 23159232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of renal anemia with darbepoetin alfa administered once every other week in predialysis patients with chronic kidney disease and previously treated with epoetin alfa].
    Molina M; García Hernández MA; Navarro MJ; Pérez Silva F; Cacho M; De Gracia MC
    Nefrologia; 2004; 24(1):54-9. PubMed ID: 15083958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of recombinant human erythropoietin for management of anemia in dogs and cats with renal failure.
    Cowgill LD; James KM; Levy JK; Browne JK; Miller A; Lobingier RT; Egrie JC
    J Am Vet Med Assoc; 1998 Feb; 212(4):521-8. PubMed ID: 9491159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietic response and outcomes in kidney disease and type 2 diabetes.
    Solomon SD; Uno H; Lewis EF; Eckardt KU; Lin J; Burdmann EA; de Zeeuw D; Ivanovich P; Levey AS; Parfrey P; Remuzzi G; Singh AK; Toto R; Huang F; Rossert J; McMurray JJ; Pfeffer MA;
    N Engl J Med; 2010 Sep; 363(12):1146-55. PubMed ID: 20843249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of darbepoetin alfa versus epoetin alfa for the treatment of chemotherapy induced anemia in patients with gynecologic malignancies.
    Case AS; Rocconi RP; Kilgore LC; Barnes MN
    Gynecol Oncol; 2006 Jun; 101(3):499-502. PubMed ID: 16406064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosing intervals and hemoglobin control in patients with chronic kidney disease and anemia treated with epoetin alfa or darbepoetin alfa: a retrospective cohort study.
    Nurko S; Spirko R; Law A; Dennis VW
    Clin Ther; 2007 Sep; 29(9):2010-21. PubMed ID: 18035200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression, bioactivity, and clinical assessment of recombinant feline erythropoietin.
    Randolph JE; Scarlett JM; Stokol T; Saunders KM; MacLeod JN
    Am J Vet Res; 2004 Oct; 65(10):1355-66. PubMed ID: 15524322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human recombinant erythropoietin used to treat a cat with anemia caused by chronic renal failure.
    Henry PA
    Can Vet J; 1994 Jun; 35(6):375. PubMed ID: 8069840
    [No Abstract]   [Full Text] [Related]  

  • 12. Darbepoetin alfa administered every other week maintains hemoglobin levels over 52 weeks in patients with chronic kidney disease converting from once-weekly recombinant human erythropoietin: results from simplify the treatment of anemia with Aranesp (STAAR).
    Hertel J; Locay H; Scarlata D; Jackson L; Prathikanti R; Audhya P
    Am J Nephrol; 2006; 26(2):149-56. PubMed ID: 16636531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of recombinant human erythropoietin and darbepoetin alpha in children.
    Can C; Emre S; Bilge I; Yilmaz A; Şirin A
    Pediatr Int; 2013 Jun; 55(3):296-9. PubMed ID: 23461764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement in erythropoieis-stimulating agent-induced pure red-cell aplasia by introduction of darbepoetin-α when the anti-erythropoietin antibody titer declines spontaneously.
    Lee H; Yang J; Kim H; Kwon JW; Oh KH; Joo KW; Kim YS; Ahn C; Han JS; Kim S
    J Korean Med Sci; 2010 Nov; 25(11):1676-9. PubMed ID: 21060762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current issues in erythropoietin therapy of renal anemia].
    Zakar G
    Lege Artis Med; 2007 Oct; 17(10):667-73. PubMed ID: 19227596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomedical system dynamics to improve anemia control with darbepoetin alfa in long-term hemodialysis patients.
    McCarthy JT; Hocum CL; Albright RC; Rogers J; Gallaher EJ; Steensma DP; Gudgell SF; Bergstralh EJ; Dillon JC; Hickson LJ; Williams AW; Dingli D
    Mayo Clin Proc; 2014 Jan; 89(1):87-94. PubMed ID: 24388026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, controlled trial of darbepoetin alfa for the treatment of anemia in hemodialysis patients.
    Nissenson AR; Swan SK; Lindberg JS; Soroka SD; Beatey R; Wang C; Picarello N; McDermott-Vitak A; Maroni BJ
    Am J Kidney Dis; 2002 Jul; 40(1):110-8. PubMed ID: 12087568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of anemia treatment with darbepoetin alfa and erythropoietin beta in patients with chronic kidney disease].
    Wanic-Kossowska M
    Pol Merkur Lekarski; 2010 Jan; 28(163):13-7. PubMed ID: 20369716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized study of darbepoetin alfa and recombinant human erythropoietin for treatment of renal anemia in chronic renal failure patients receiving peritoneal dialysis.
    Li WY; Chu TS; Huang JW; Wu MS; Wu KD
    J Formos Med Assoc; 2008 Nov; 107(11):843-50. PubMed ID: 18971153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacological and clinical profiles of long-lasting erythropoiesis-stimulating agent (darbepoetin alfa; NESP].
    Nagano N
    Nihon Yakurigaku Zasshi; 2008 Apr; 131(4):291-9. PubMed ID: 18408341
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.